Albert Oriol Selected Research

pomalidomide

1/2022	Health-related quality of life in patients with relapsed/refractory multiple myeloma treated with pomalidomide and dexamethasone ± subcutaneous daratumumab: Patient-reported outcomes from the APOLLO trial.
1/2022	Pomalidomide, bortezomib, and dexamethasone at first relapse in lenalidomide-pretreated myeloma: A subanalysis of OPTIMISMM by clinical characteristics.
1/2021	Daratumumab plus pomalidomide and dexamethasone versus pomalidomide and dexamethasone alone in previously treated multiple myeloma (APOLLO): an open-label, randomised, phase 3 trial.
1/2021	Isatuximab, carfilzomib, and dexamethasone in relapsed multiple myeloma (IKEMA): a multicentre, open-label, randomised phase 3 trial.
1/2021	Filanesib in combination with pomalidomide and dexamethasone in refractory MM patients: safety and efficacy, and association with alpha 1-acid glycoprotein (AAG) levels. Phase Ib/II Pomdefil clinical trial conducted by the Spanish MM group.
9/2019	Pembrolizumab plus pomalidomide and dexamethasone for patients with relapsed or refractory multiple myeloma (KEYNOTE-183): a randomised, open-label, phase 3 trial.
5/2019	Pomalidomide-dexamethasone for treatment of soft-tissue plasmacytomas in patients with relapsed / refractory multiple myeloma.
1/2019	Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial.
1/2018	Comparative Efficacy of Daratumumab Monotherapy and Pomalidomide Plus Low-Dose Dexamethasone in the Treatment of Multiple Myeloma: A Matching Adjusted Indirect Comparison.
9/2017	Adverse event management in patients with relapsed and refractory multiple myeloma taking pomalidomide plus low-dose dexamethasone: A pooled analysis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Albert Oriol Research Topics

Disease

101	Multiple Myeloma 06/2022 - 10/2006
18	Neoplasms (Cancer) 01/2022 - 10/2007
10	Disease Progression 01/2022 - 11/2012
8	Pneumonia (Pneumonitis) 01/2021 - 11/2011
7	Infections 01/2022 - 04/2003
7	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2018 - 02/2003
7	Leukemia 10/2014 - 04/2003
6	Neutropenia 01/2021 - 07/2012
6	Thrombocytopenia (Thrombopenia) 01/2021 - 07/2012
6	Residual Neoplasm 10/2020 - 01/2012
6	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2016 - 05/2005
6	Lymphoma (Lymphomas) 12/2014 - 09/2002
6	Burkitt Lymphoma (Burkitt's Lymphoma) 10/2014 - 04/2003
6	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 05/2014 - 09/2005
5	Peripheral Nervous System Diseases (PNS Diseases) 08/2021 - 10/2010
5	AIDS-Related Lymphoma (Lymphoma, AIDS Related) 11/2014 - 09/2002
5	Pathologic Complete Response 10/2010 - 10/2005
4	Chromosome Aberrations (Chromosome Abnormalities) 01/2022 - 09/2007
4	Fatigue 10/2017 - 06/2010
3	Hypertension (High Blood Pressure) 12/2020 - 01/2016
3	Heart Arrest (Cardiac Arrest) 09/2019 - 10/2017
3	Smoldering Multiple Myeloma 01/2019 - 08/2013
3	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 04/2017 - 02/2008
3	Acquired Immunodeficiency Syndrome (AIDS) 03/2011 - 07/2005
3	B-Cell Lymphoma (Lymphoma, B Cell) 11/2007 - 04/2003
2	Waldenstrom Macroglobulinemia (Macroglobulinemia) 11/2021 - 12/2020
2	Paraproteinemias (Monoclonal Gammopathy) 10/2021 - 08/2014
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2020 - 04/2017
2	Myocarditis (Carditis) 09/2019 - 09/2019
2	Respiratory Insufficiency (Respiratory Failure) 09/2019 - 11/2011
2	Sepsis (Septicemia) 09/2019 - 09/2019
2	Immunoglobulin Light-chain Amyloidosis 01/2019 - 09/2015
2	Septic Shock (Toxic Shock Syndrome) 10/2017 - 11/2011
2	Anemia 02/2017 - 10/2016
2	Philadelphia Chromosome 11/2012 - 01/2010
2	HIV Infections (HIV Infection) 07/2008 - 04/2003
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 11/2007 - 10/2005
1	Body Weight (Weight, Body) 11/2022
1	Circulating Neoplastic Cells 01/2022
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2021

Drug/Important Bio-Agent (IBA)

51	Dexamethasone (Maxidex)FDA LinkGeneric 06/2022 - 10/2007
34	Bortezomib (Velcade)FDA Link 01/2022 - 10/2006
31	Lenalidomide (CC 5013)FDA Link 01/2022 - 03/2011
16	pomalidomideIBA 01/2022 - 10/2013
16	Prednisone (Sone)FDA LinkGeneric 08/2021 - 05/2005
15	daratumumabIBA 01/2022 - 04/2016
14	carfilzomibIBA 06/2022 - 01/2015
12	Melphalan (Alkeran)FDA LinkGeneric 08/2021 - 10/2006
9	Monoclonal AntibodiesIBA 06/2022 - 04/2016
9	Cyclophosphamide (Cytoxan)FDA LinkGeneric 04/2017 - 05/2005
8	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2018
8	Rituximab (Mabthera)FDA Link 11/2021 - 09/2002
7	Proteasome InhibitorsIBA 01/2022 - 01/2015
7	Pharmaceutical PreparationsIBA 01/2021 - 07/2012
7	Thalidomide (Thalomid)FDA Link 01/2018 - 10/2010
6	Vincristine (Oncovin)FDA LinkGeneric 01/2016 - 05/2005
5	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2019
5	Immunomodulating AgentsIBA 01/2021 - 09/2015
4	Alkylating AgentsIBA 05/2021 - 09/2014
4	pembrolizumabIBA 12/2020 - 09/2019
4	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2016 - 02/2008
3	melflufenIBA 01/2022 - 10/2020
3	ibrutinibIBA 11/2021 - 05/2020
3	Biological ProductsIBA 01/2021 - 01/2018
3	Nerve Growth Factor (NGF)IBA 01/2021 - 10/2020
3	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2014 - 07/2004
2	isatuximabIBA 06/2022 - 01/2021
2	ParaproteinsIBA 01/2022 - 05/2019
2	Chimeric Antigen ReceptorsIBA 01/2021 - 01/2020
2	AminopeptidasesIBA 01/2021 - 10/2020
2	idecabtagene vicleucelIBA 01/2021 - 01/2021
2	B-Cell Maturation AntigenIBA 01/2021 - 01/2021
2	AntibodiesIBA 01/2021 - 01/2020
2	Peptides (Polypeptides)IBA 01/2021 - 10/2020
2	Decitabine FDA Link 01/2018 - 07/2012
2	fludarabineIBA 04/2017 - 02/2008
2	Mitoxantrone (Novantrone)FDA LinkGeneric 04/2017 - 02/2008
2	Etoposide (VP 16)FDA LinkGeneric 11/2013 - 02/2003
2	Imatinib Mesylate (Gleevec)FDA Link 01/2010 - 09/2007
2	Protons (Proton)IBA 11/2009 - 04/2007
2	Methotrexate (Mexate)FDA LinkGeneric 02/2007 - 11/2005
2	AntigensIBA 01/2006 - 09/2005
1	Serum AlbuminIBA 01/2022
1	Protein Isoforms (Isoforms)IBA 01/2022
1	Immunoglobulin A (IgA)IBA 01/2022
1	Clarithromycin (Biaxin)FDA LinkGeneric 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Death Domain ReceptorsIBA 01/2021
1	LigandsIBA 01/2021

Therapy/Procedure

39	Therapeutics 01/2022 - 04/2003
18	Stem Cell Transplantation 12/2021 - 07/2004
16	Drug Therapy (Chemotherapy) 10/2015 - 09/2002
7	Highly Active Antiretroviral Therapy (HAART) 02/2008 - 09/2002
5	Aftercare (After-Treatment) 12/2020 - 10/2005
3	Transplantation 01/2020 - 11/2011
3	Immunotherapy 01/2020 - 07/2008
3	Hematopoietic Stem Cell Transplantation 05/2014 - 07/2004
2	Maintenance Chemotherapy 01/2007 - 10/2005
1	Subcutaneous Injections 11/2022
1	Duration of Therapy 08/2021